Takeda - Better Health, Brighter Future

Better Health, Brighter Future

Our Coronavirus Efforts

How we are responding to the COVID-19 pandemic

LEARN MORE

Welcome to the global
corporate site for Takeda.

If you are looking for specific information,
please visit our country/region website.

SELECT A COUNTRY OR REGION SITE

Working with Communities to Help Build Foundations for a New Life

Coronavirus: Adjusting Our Business Approach While Serving Our Patients

RECENT NEWS STOCK PRICE

Mar 23, 2020 Mar 23, 2020

Takeda Receives Approval of Entyvio^® (Vedolizumab) in China for the Treatment of Patients with Moderate to Severe Active Ulcerative Colitis (UC) and Crohn's Disease (CD)

Please wait...

Topics

Approach to the Environment

TAKEDA LIFE THEATER

Quarterly Announcements FY 2019 Q3 Results

Rajeev Venkayya, President, Global Vaccine Business Unit on the latest on the Coronavirus and Takeda

Information

FY2019 Q3 Financial Results Announcement (3:00pm JST on February 4^th, 2020)
Q3 Results Conference Call (presentation & Q&A): 6:00pm-7:00pm JST
Alternative Timezone Conference Call (Q&A only): 10:00pm-11:00pm JST

38^thAnnual J.P. Morgan Healthcare Conference (4:00pm-4:55pm January 14, 2020 PST)

Information for US patients regarding the NATPARA recall in the US.
NATPARA is still available in markets outside of the US.

Offer for Shire plc

Copyright 1995-2020 Takeda Pharmaceutical Company Limited. All rights reserved.